Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts

F Yang, Z Ning, L Ma, W Liu, C Shao, Y Shu, H Shen - Molecular cancer, 2017 - Springer
Purpose The present review aimed to assess the role of exosomal miRNAs in cancer-
associated fibroblasts (CAFs), normal fibroblasts (NFs), and cancer cells. The roles of …

Integrins, CAFs and mechanical forces in the progression of cancer

I Jang, KA Beningo - Cancers, 2019 - mdpi.com
Cells respond to both chemical and mechanical cues present within their microenvironment.
Various mechanical signals are detected by and transmitted to the cells through …

Role of serine proteases at the tumor-stroma interface

R Tagirasa, E Yoo - Frontiers in immunology, 2022 - frontiersin.org
During tumor development, invasion and metastasis, the intimate interaction between tumor
and stroma shapes the tumor microenvironment and dictates the fate of tumor cells. Stromal …

Circulating extracellular vesicles are monitoring biomarkers of anti-PD1 response and enhancer of tumor progression and immunosuppression in metastatic …

S Serratì, R Di Fonte, L Porcelli, S De Summa… - Journal of Experimental …, 2023 - Springer
Background Clinical drawback in checkpoint inhibitors immunotherapy (ICI) of metastatic
melanoma (MM) is monitoring clinical benefit. Soluble forms of PD1 (sPD1) and PD-L1 (sPD …

[HTML][HTML] Gold nanoparticles inhibit activation of cancer-associated fibroblasts by disrupting communication from tumor and microenvironmental cells

Y Zhang, CK Elechalawar, MN Hossen, ER Francek… - Bioactive materials, 2021 - Elsevier
Cancer-associated fibroblasts (CAFs) are a major constituent of the tumor microenvironment
(TME) and an important contributor to cancer progression and therapeutic resistance …

[HTML][HTML] European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma

B Bruno, R Wäsch, M Engelhardt, F Gay… - …, 2021 - ncbi.nlm.nih.gov
Chimeric antigen receptor (CAR) T cells (CAR-T) have dramatically changed the treatment
landscape of B-cell malignancies, providing a potential cure for relapsed/refractory patients …

Immunosuppressive MFAP2+ cancer associated fibroblasts conferred unfavorable prognosis and therapeutic resistance in gastric cancer

R Wei, J Song, X Liu, S Huo, C Liu, X Liu - Cellular Oncology, 2024 - Springer
Purpose To explore the predictive merit of MFAP2+ cancer associated fibroblasts (CAFs)
infiltration for clinical outcomes and adjuvant chemotherapy or immunotherapy …

Presence of bone marrow fibrosis in multiple myeloma may predict extramedullary disease

M Koshiishi, I Kawashima, H Hyuga… - International Journal of …, 2022 - Springer
We analyzed the incidence of bone marrow fibrosis in 91 newly diagnosed Japanese
multiple myeloma (MM) patients and evaluated the impact of fibrosis on clinical …

Cancer-associated fibroblasts differentiated by exosomes isolated from cancer cells promote cancer cell invasion

K Kim, YJ Sohn, R Lee, HJ Yoo, JY Kang… - International journal of …, 2020 - mdpi.com
Cancer-associated fibroblasts (CAFs) in the cancer microenvironment play an essential role
in metastasis. Differentiation of endothelial cells into CAFs is induced by cancer cell-derived …

EGFR/uPAR interaction as druggable target to overcome vemurafenib acquired resistance in melanoma cells

A Laurenzana, F Margheri, A Biagioni, A Chillà… - …, 2019 - thelancet.com
Abstract Background BRAF inhibitor (BRAF-I) therapy for melanoma patients harboring the
V600E mutation is initially highly effective, but almost all patients relapse within a few …